Hodgkin's Lymphoma - The Great Teacher

被引:24
作者
Connors, Joseph M. [1 ]
机构
[1] BC Canc Agcy Ctr Lymphoid Canc, Vancouver, BC, Canada
关键词
CHEMOTHERAPY; BEACOPP; ABVD;
D O I
10.1056/NEJMe1104576
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:264 / 265
页数:2
相关论文
共 8 条
[1]   Involved-field radiotherapy for advanced Hodgkin's lymphoma [J].
Aleman, BMP ;
Raemaekers, JMM ;
Tirelli, U ;
Bortolus, R ;
van't Veer, MB ;
Lybeert, MLM ;
Keuning, JJ ;
Carde, P ;
Girinsky, T ;
van der Maazen, RWM ;
Tomsic, R ;
Vovk, M ;
van Hoof, A ;
Demeestere, G ;
Lugtenburg, PJ ;
Thomas, J ;
Schroyens, W ;
De Boeck, K ;
Baars, JW ;
Kluin-Nelemans, JC ;
Carrie, C ;
Aoudjhane, M ;
Bron, D ;
Eghbali, H ;
Smit, WGJM ;
Meerwaldt, JH ;
Hagenbeek, A ;
Pinna, A ;
Henry-Amar, M .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (24) :2396-2406
[2]  
Diehl V, 2004, BLOOD, V104, p91A
[3]   Reduced Treatment Intensity in Patients with Early-Stage Hodgkin's Lymphoma [J].
Engert, Andreas ;
Pluetschow, Annette ;
Eich, Hans Theodor ;
Lohri, Andreas ;
Doerken, Bernd ;
Borchmann, Peter ;
Berger, Bernhard ;
Greil, Richard ;
Willborn, Kay C. ;
Wilhelm, Martin ;
Debus, Juergen ;
Eble, Michael J. ;
Soekler, Martin ;
Ho, Antony ;
Rank, Andreas ;
Ganser, Arnold ;
Truemper, Lorenz ;
Bokemeyer, Carsten ;
Kirchner, Hartmut ;
Schubert, Joerg ;
Kral, Zdenek ;
Fuchs, Michael ;
Mueller-Hermelink, Hans-Konrad ;
Mueller, Rolf-Peter ;
Diehl, Volker .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (07) :640-652
[4]   Escalated-Dose BEACOPP in the Treatment of Patients With Advanced-Stage Hodgkin's Lymphoma: 10 Years of Follow-Up of the GHSG HD9 Study [J].
Engert, Andreas ;
Diehl, Volker ;
Franklin, Jeremy ;
Lohri, Andreas ;
Doerken, Bernd ;
Ludwig, Wolf-Dieter ;
Koch, Peter ;
Haenel, Mathias ;
Pfreundschuh, Michael ;
Wilhelm, Martin ;
Truemper, Lorenz ;
Aulitzky, Walter-Erich ;
Bentz, Martin ;
Rummel, Mathias ;
Sezer, Orhan ;
Mueller-Hermelink, Hans-Konrad ;
Hasenclever, Dirk ;
Loeffler, Markus .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (27) :4548-4554
[5]   High-dose chemotherapy and autologous stem cell transplantation for primary refractory or relapsed Hodgkin lymphoma: long-term outcome in the first 100 patients treated in Vancouver [J].
Lavoie, JC ;
Connors, JM ;
Phillips, GL ;
Reece, DE ;
Barnett, MJ ;
Forrest, DL ;
Gascoyne, RD ;
Hogge, DE ;
Nantel, SH ;
Shepherd, JD ;
Smith, CA ;
Song, KW ;
Sutherland, HJ ;
Toze, CL ;
Voss, NJS ;
Nevill, TJ .
BLOOD, 2005, 106 (04) :1473-1478
[6]   Randomized comparison of ABVD chemotherapy with a strategy that includes radiation therapy in patients with limited-stage Hodgkin's lymphoma: National Cancer Institute of Canada Clinical Trials Group and the Eastern Cooperative Oncology Group [J].
Meyer, RM ;
Gospodarowicz, MK ;
Connors, JM ;
Pearcey, RG ;
Bezjak, A ;
Wells, WA ;
Burns, BE ;
Winter, JN ;
Horning, SJ ;
Dar, AR ;
Djurfeldt, MS ;
Ding, K ;
Shepherd, LE .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (21) :4634-4642
[7]  
Moccia AA, 2009, BLOOD, V114, P622
[8]   ABVD versus BEACOPP for Hodgkin's Lymphoma When High-Dose Salvage Is Planned [J].
Viviani, Simonetta ;
Zinzani, Pier Luigi ;
Rambaldi, Alessandro ;
Brusamolino, Ercole ;
Levis, Alessandro ;
Bonfante, Valeria ;
Vitolo, Umberto ;
Pulsoni, Alessandro ;
Liberati, Anna Marina ;
Specchia, Giorgina ;
Valagussa, Pinuccia ;
Rossi, Andrea ;
Zaja, Francesco ;
Pogliani, Enrico M. ;
Pregno, Patrizia ;
Gotti, Manuel ;
Gallamini, Andrea ;
Scalabrini, Delia Rota ;
Bonadonna, Gianni ;
Gianni, Alessandro M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (03) :203-212